Inhibrxinc Stock Probability of Future Stock Price Finishing Over 24.58
| INBX Stock | USD 34.45 0.16 0.46% |
Closest to current price InhibrxInc long CALL Option Payoff at Expiration
InhibrxInc |
InhibrxInc Target Price Odds to finish over 24.58
The tendency of InhibrxInc Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 24.58 in 90 days |
| 34.45 | 90 days | 24.58 | close to 99 |
Based on a normal probability distribution, the odds of InhibrxInc to stay above $ 24.58 in 90 days from now is close to 99 (This InhibrxInc probability density function shows the probability of InhibrxInc Stock to fall within a particular range of prices over 90 days) . Probability of InhibrxInc price to stay between $ 24.58 and its current price of $34.45 at the end of the 90-day period is about 15.25 .
Given the investment horizon of 90 days InhibrxInc has a beta of 0.62. This usually indicates as returns on the market go up, InhibrxInc average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding InhibrxInc will be expected to be much smaller as well. Additionally InhibrxInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. InhibrxInc Price Density |
| Price |
Predictive Modules for InhibrxInc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InhibrxInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of InhibrxInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
InhibrxInc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. InhibrxInc is not an exception. The market had few large corrections towards the InhibrxInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold InhibrxInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of InhibrxInc within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.05 | |
β | Beta against NYSE Composite | 0.62 | |
σ | Overall volatility | 1.60 | |
Ir | Information ratio | -0.04 |
InhibrxInc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of InhibrxInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for InhibrxInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| InhibrxInc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.8 M. Net Loss for the year was (241.36 M) with loss before overhead, payroll, taxes, and interest of (107.99 M). | |
| InhibrxInc currently holds about 176.38 M in cash with (193.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.52. | |
| InhibrxInc has a frail financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: As more rare disease therapies launch, their prices are rising |
InhibrxInc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of InhibrxInc Stock often depends not only on the future outlook of the current and potential InhibrxInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InhibrxInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.1 M | |
| Cash And Short Term Investments | 277.9 M |
InhibrxInc Technical Analysis
InhibrxInc's future price can be derived by breaking down and analyzing its technical indicators over time. InhibrxInc Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InhibrxInc. In general, you should focus on analyzing InhibrxInc Stock price patterns and their correlations with different microeconomic environments and drivers.
InhibrxInc Predictive Forecast Models
InhibrxInc's time-series forecasting models is one of many InhibrxInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary InhibrxInc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about InhibrxInc
Checking the ongoing alerts about InhibrxInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for InhibrxInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| InhibrxInc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.8 M. Net Loss for the year was (241.36 M) with loss before overhead, payroll, taxes, and interest of (107.99 M). | |
| InhibrxInc currently holds about 176.38 M in cash with (193.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.52. | |
| InhibrxInc has a frail financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: As more rare disease therapies launch, their prices are rising |
Check out InhibrxInc Backtesting, InhibrxInc Valuation, InhibrxInc Correlation, InhibrxInc Hype Analysis, InhibrxInc Volatility, InhibrxInc History as well as InhibrxInc Performance. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.